Martin Mackay

Type: Person
Name: Martin Mackay
First reported 19 hours ago - Updated 19 hours ago - 1 reports

Alexion Pharmaceuticals (ALXN) Earnings Report: Q3 2014 Conference Call Transcript

The following Alexion Pharmaceuticals conference call took place on October 23, 2014, 10:00 AM ET. This is a transcript of that earnings call: Company Participants Irving Adler; Alexion Pharmaceuticals; Executive Director – Corporate Communications ... [Published Litchfield County Times - 19 hours ago]
First reported Oct 24 2014 - Updated Oct 24 2014 - 1 reports

Le Prevost back in GFC squad

Guernsey FC will travel to Carshalton Athletic on Saturday.Alex Le Prevost who had been out with a broken arm returns from injury.Chris Tardif, Tom Martin, Ryan-Zico Black and Glyn Dyer are also back in the squad.Carshalton are five places below the Green ... [Published itv.com - Oct 24 2014]
First reported Oct 23 2014 - Updated Oct 24 2014 - 1 reports

Celgene, Alexion Earnings Top Views, Send Stocks Flying

Celgene and Alexion Pharmaceuticals stocks jumped Thursday after both big-cap biotechs beat third-quarter estimates and raised their guidance.Celgene earnings rose 24% vs. a year earlier to 97 cents a share excluding one-time items, beating analysts' ... [Published Yahoo! Finance - Oct 23 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 1 reports

Alexion, Cincinnati Children’s launch rare disease innovation fund

Alexion Pharmaceuticals , a Cambridge, Mass.-based developer of breakthrough therapies for patients with severe and life-threatening rare diseases, and  Cincinnati Children’s Hospital Medical Center have established the Alexion Rare Disease Innovation ... [Published Center Watch - Oct 16 2014]
First reported Sep 24 2014 - Updated Sep 24 2014 - 1 reports

Asfotase Alfa Granted Orphan Drug Designation in Japan

By a News Reporter-Staff News Editor at Biotech Week Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) to asfotase alfa for the treatment of patients ... [Published Pharmacy Choice - Sep 24 2014]
First reported Sep 20 2014 - Updated Sep 20 2014 - 1 reports

Alexion Pharmaceuticals : Asfotase Alfa Secures Orphan Drug Designation in Japan

Alexion Pharmaceuticals recently reported that Japan's Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) to asfotase alfa for the treatment of patients with hypophosphatasia (HPP), a genetic, chronic and progressive ... [Published 4 Traders - Sep 20 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Paediatric Patients with Hypophosphatasia Receiving Investigational Asfotase Alfa Had Sustained Improvements in Growth and Physical Function

--Data from Phase 2 Extension Studies Presented at ESPE Meeting--DUBLIN, Ireland--(BUSINESS WIRE)--September 19, 2014--Alexion Pharmaceuticals today announced that researchers presented data from the open-label extension phases of two Phase 2 studies ... [Published Scottrade - Sep 19 2014]

Quotes

...and there are currently no approved treatment options," said Martin Mackay, Ph D , Executive Vice President, Global Head of R&D at Alexion. "the orphan drug designation granted for asfotase alfa undescores the significant need for an effective treatment option for japanese patients suffering from this severe, ultra-rare disorder."
"paediatric patients with severe hpp face significant challenges related to growth, development and physical function" said Martin Mackay, Ph D , Executive Vice President and Global Head of R&D at Alexion...
"mdc1a is a disease that aligns very well with our passion to develop and deliver first-in-class drug candidates that have the potential to transform the lives of people suffering with devastating disorders that currently have no treatment options" said Martin Mackay, Ph D , executive vice president, head of Global Research & Development at Alexion...

More Content

All (10) | News (10) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Alexion Pharmaceuticals (ALXN) Earnings Report:... [Published Litchfield County Times - 19 hours ago]
Le Prevost back in GFC squad [Published itv.com - Oct 24 2014]
Celgene, Alexion Earnings Top Views, Send Stock... [Published Yahoo! Finance - Oct 23 2014]
Alexion Pharmaceuticals' (ALXN) CEO Leonard Bel... [Published Seeking Alpha - Oct 23 2014]
Alexion, Cincinnati Children’s launch rare dise... [Published Center Watch - Oct 16 2014]
Asfotase Alfa Granted Orphan Drug Designation i... [Published Pharmacy Choice - Sep 24 2014]
Alexion Pharmaceuticals : Asfotase Alfa Secures... [Published 4 Traders - Sep 20 2014]
Paediatric Patients with Hypophosphatasia Recei... [Published Scottrade - Sep 19 2014]
Prothelia, University of Nevada sign agreements... [Published PharmaBiz - Feb 15 2014]
Prothelia and the University of Nevada, Reno En... [Published PR Newswire - Feb 13 2014]
1
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.